TY - JOUR
T1 - Sleep-Related Breathing Disorders in Multiple Sclerosis: Prevalence, Features and Associated Factors
AU - Sparasci, Davide
AU - Fanfulla, Francesco
AU - Ferri, Raffaele
AU - Aricò, Debora
AU - Distefano, Daniela
AU - Pravatà, Emanuele
AU - Heinzer, Raphael
AU - Haba-Rubio, José
AU - Berger, Mathieu
AU - Riccitelli, Gianna Carla
AU - Gobbi, Claudio
AU - Zecca, Chiara
AU - Manconi, Mauro
N1 - Funding Information:
R.F. was partially supported by a fund of the Italian Ministry of Health (RC2764026). CZ reports grants from Swiss MS Society, during the conduct of the study; grants from Abbvie, Almirall, Biogen Idec, Bristol Meyer Squibb, Genzyme, Lundbeck, Merck, Novartis, Teva Pharma, and Roche, outside the submitted work. The authors report no other conflicts of interest in this work.
Funding Information:
Grant ABREOC from Ente Ospedaliero Cantonale (EOC); Grant Swiss MS Society (SMSS); Swiss National Science Foundation, grant number: 320030_160250. The authors want to thank all the patients and participants involved in the study. Special thanks are due to Ente Ospedaliero Cantonale (EOC), Swiss MS Society and Swiss National Science Foundation, for the financial support.
Publisher Copyright:
© 2022 Sparasci et al.
PY - 2022
Y1 - 2022
N2 - Background: Multiple sclerosis (MS) represents a risk factor for sleep disorders, but there are conflicting results about the prevalence and severity of sleep-related breathing disorders (SRBD) in MS. Most available data come from self-administered questionnaires. Objective: To conduct a polysomnographic study in MS focused on SRBD, compared to a group of healthy controls (HC), also considering the neuroimaging findings. To evaluate the impact of SRBD on vigilance, fatigue and depression in MS. Methods: In this cross-sectional, observational, instrumental study, 67 MS patients (men/women: 20/47; mean age: 50.6±8.2 years) underwent PSG and maintenance of wakefulness test. Findings were compared to 67 age-, sex-, BMI-matched HC, by using parametric (Student’s t-test) and nonparametric statistics (chi-squared test). A subgroup analysis was then performed, evaluating the influence of brainstem (mesencephalic, pontine and medullary) lesions at neuroimaging on instrumental and clinical data: MS patients with at least one brainstem lesion vs MS patients without vs HC. Results: The frequency of SRBD was comparable in MS patients and HC. No MS patient had a central apnea index ≥2/h. The respiratory disturbance index (RDI) did not correlate to clinical parameters such as fatigue and depression. Patients with MS were drowsier than HC (47% vs 26%, p = 0.019) and showed a worse sleep pattern, in terms of duration, efficiency and architecture. Conclusion: Our study does not provide evidence of an association between MS-specific symptoms such as fatigue, sleepiness, depression and central or obstructive apneas, even in the presence of brainstem lesions.
AB - Background: Multiple sclerosis (MS) represents a risk factor for sleep disorders, but there are conflicting results about the prevalence and severity of sleep-related breathing disorders (SRBD) in MS. Most available data come from self-administered questionnaires. Objective: To conduct a polysomnographic study in MS focused on SRBD, compared to a group of healthy controls (HC), also considering the neuroimaging findings. To evaluate the impact of SRBD on vigilance, fatigue and depression in MS. Methods: In this cross-sectional, observational, instrumental study, 67 MS patients (men/women: 20/47; mean age: 50.6±8.2 years) underwent PSG and maintenance of wakefulness test. Findings were compared to 67 age-, sex-, BMI-matched HC, by using parametric (Student’s t-test) and nonparametric statistics (chi-squared test). A subgroup analysis was then performed, evaluating the influence of brainstem (mesencephalic, pontine and medullary) lesions at neuroimaging on instrumental and clinical data: MS patients with at least one brainstem lesion vs MS patients without vs HC. Results: The frequency of SRBD was comparable in MS patients and HC. No MS patient had a central apnea index ≥2/h. The respiratory disturbance index (RDI) did not correlate to clinical parameters such as fatigue and depression. Patients with MS were drowsier than HC (47% vs 26%, p = 0.019) and showed a worse sleep pattern, in terms of duration, efficiency and architecture. Conclusion: Our study does not provide evidence of an association between MS-specific symptoms such as fatigue, sleepiness, depression and central or obstructive apneas, even in the presence of brainstem lesions.
KW - multiple sclerosis
KW - polysomnography
KW - sleep quality
KW - sleep-related breathing disorders
UR - http://www.scopus.com/inward/record.url?scp=85129127549&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129127549&partnerID=8YFLogxK
U2 - 10.2147/NSS.S359858
DO - 10.2147/NSS.S359858
M3 - Article
C2 - 35478718
AN - SCOPUS:85129127549
SN - 1179-1608
VL - 14
SP - 741
EP - 750
JO - Nature and Science of Sleep
JF - Nature and Science of Sleep
ER -